Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Cherian

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Structure (London, England : 1993)|January 17, 2012
Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824Susan E Cellitti, Jennifer Shaffer, David H Jones, et al.
Cell Host & Microbe|March 11, 2008
Selective killing of nonreplicating mycobacteriaRuslana Bryk, Benjamin Gold, Aditya Venugopal, et al.
Protein Science : a Publication of the Protein Society|February 15, 2024
Identification of small-molecule binding sites of a ubiquitin-conjugating enzyme-UBE2T through fragment-based screeningYong Yao Loh, Jothi Anantharajan, Qiwei Huang, et al.
Journal of Medicinal Chemistry|July 16, 2011
Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824)Joseph Cherian, Inhee Choi, Amit Nayyar, et al.
Aging Medicine (Milton (N.S.W))|July 7, 2025
A Phase 3 Multicenter, Double-Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal OsteoporosisNitin Kapoor, Thomas Paul, Rajeshwar Nath Srivastava, et al.
Journal of the American Chemical Society|October 30, 2024
Button-Push On-Demand Synthesis for Rapid Optimization of Antiviral PeptidomimeticsDuanshuai Tian, Ting Wei Tan, Ronald Toh Kuan Hai, et al.
Osteoarthritis and Cartilage Open|January 15, 2026
Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 studyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
European Journal of Medicinal Chemistry|August 21, 2018
Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteriaSoo Yei Ho, Weiling Wang, Fui Mee Ng, et al.
The American Journal of Sports Medicine|June 27, 2023
Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled StudyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
Journal of Medicinal Chemistry|April 25, 2018
Fragment-Based Drug Discovery of Potent Protein Kinase C Iota InhibitorsJacek Kwiatkowski, Boping Liu, Doris Hui Ying Tee, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Structure (London, England : 1993)|January 17, 2012
Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824Susan E Cellitti, Jennifer Shaffer, David H Jones, et al.
Cell Host & Microbe|March 11, 2008
Selective killing of nonreplicating mycobacteriaRuslana Bryk, Benjamin Gold, Aditya Venugopal, et al.
Protein Science : a Publication of the Protein Society|February 15, 2024
Identification of small-molecule binding sites of a ubiquitin-conjugating enzyme-UBE2T through fragment-based screeningYong Yao Loh, Jothi Anantharajan, Qiwei Huang, et al.
Journal of Medicinal Chemistry|July 16, 2011
Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824)Joseph Cherian, Inhee Choi, Amit Nayyar, et al.
Aging Medicine (Milton (N.S.W))|July 7, 2025
A Phase 3 Multicenter, Double-Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal OsteoporosisNitin Kapoor, Thomas Paul, Rajeshwar Nath Srivastava, et al.
Journal of the American Chemical Society|October 30, 2024
Button-Push On-Demand Synthesis for Rapid Optimization of Antiviral PeptidomimeticsDuanshuai Tian, Ting Wei Tan, Ronald Toh Kuan Hai, et al.
Osteoarthritis and Cartilage Open|January 15, 2026
Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 studyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
European Journal of Medicinal Chemistry|August 21, 2018
Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteriaSoo Yei Ho, Weiling Wang, Fui Mee Ng, et al.
The American Journal of Sports Medicine|June 27, 2023
Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled StudyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
Journal of Medicinal Chemistry|April 25, 2018
Fragment-Based Drug Discovery of Potent Protein Kinase C Iota InhibitorsJacek Kwiatkowski, Boping Liu, Doris Hui Ying Tee, et al.
Pageof 5